The Role of Sacroiliac Joint Steroid Injections in the Treatment of Axial Spondyloarthritis.
Axial spondyloarthritis
fluoroscopy
intraarticular injection
sacroiliac joint
sacroiliitis
Journal
Archives of rheumatology
ISSN: 2618-6500
Titre abrégé: Arch Rheumatol
Pays: Turkey
ID NLM: 101639000
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
25
01
2020
accepted:
25
05
2020
entrez:
28
5
2021
pubmed:
29
5
2021
medline:
29
5
2021
Statut:
epublish
Résumé
This study aims to investigate the effects of fluoroscopy-guided sacroiliac joint steroid injection in patients with acute bilateral sacroiliitis diagnosed with axial spondyloarthritis (axSpA) and how those injections affect the current need for nonsteroidal anti-inflammatory drug (NSAID) usage. We retrospectively evaluated 43 patients (28 males, 15 females; mean age, 31.7±6.3 years; range, 18 to 44 years) fulfilling the Assessment of SpondyloArthritis international Society 2009 criteria for axSpA between June 2015 and May 2016. One group included 22 patients (injection group) treated with sacroiliac joint steroid injection (triamcinolone acetonide) and the other group included 21 patients (non-injection group) not receiving the injection. All 43 patients in both groups were treated with indomethacin peroral. Pre-treatment, first week and first, third and sixth month follow-up examinations were evaluated. A ≥50% reduction in the numeric rating scale score compared with the baseline was considered as significant pain relief. The mean pain relief rates in patients receiving injections were higher at all inspections. This difference was statistically significant at first week (p<0.05). When groups were compared, no difference was found in the Bath Ankylosing Spondylitis Disease Activity Index scores (p>0.05). There was no statistically significant difference between the two groups when indomethacin dose was evaluated cumulatively for six months (p>0.05). Fluoroscopy-guided sacroiliac joint steroid injections can be recommended in patients with active sacroiliitis, particularly in those with severe axial pain, for rapid analgesia in the initial term. It was concluded that steroid injections applied to the sacroiliac joint did not affect disease activity. It is noteworthy that there is a trend to reduce the use of NSAIDs in patients receiving these injections, although it does not make a statistically significant difference in the long term.
Identifiants
pubmed: 34046572
doi: 10.46497/ArchRheumatol.2021.8043
pmc: PMC8140859
doi:
Types de publication
Journal Article
Langues
eng
Pagination
80-88Informations de copyright
Copyright © 2020, Turkish League Against Rheumatism.
Déclaration de conflit d'intérêts
Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
Références
J Comput Assist Tomogr. 1996 Jul-Aug;20(4):512-21
pubmed: 8708047
Joint Bone Spine. 2020 May;87(3):209-213
pubmed: 31216488
Ann Rheum Dis. 2011 Jun;70(6):905-8
pubmed: 21540200
Arthritis Rheum. 1992 May;35(5):564-8
pubmed: 1575790
Joint Bone Spine. 2013 Dec;80(6):582-5
pubmed: 23578940
Br J Rheumatol. 1996 Aug;35(8):767-70
pubmed: 8761190
J Rheumatol. 2016 Sep;43(9):1680-6
pubmed: 27307522
Ann Rheum Dis. 2009 Jun;68(6):777-83
pubmed: 19297344
J Pharm Pharm Sci. 2014;17(3):324-61
pubmed: 25224347
Arthritis Rheum. 1984 Apr;27(4):361-8
pubmed: 6231933
Immunotherapy. 2015;7(4):353-61
pubmed: 25917627
Rheumatol Int. 2005 May;25(4):280-4
pubmed: 14730386
Rheumatology (Oxford). 2010 Aug;49(8):1479-82
pubmed: 20019067
Acta Radiol. 2002 Jul;43(4):425-7
pubmed: 12225487
Clin Rheumatol. 2008 Oct;27(10):1275-82
pubmed: 18458988
Rheum Dis Clin North Am. 2012 Aug;38(3):635-42
pubmed: 23083760
Clin Rheumatol. 2000;19(1):51-7
pubmed: 10752500
Rheumatol Int. 2006 Mar;26(5):396-400
pubmed: 16010559
Ann Rheum Dis. 2016 Nov;75(11):1958-1963
pubmed: 26768408
PM R. 2012 Jul;4(7):473-8
pubmed: 22543036